Article Information
vol. 58 no. suppl 65
Published By
Print ISSN
Online ISSN
History
- Published online November 25, 2021.
Copyright & Usage
Copyright ©the authors 2021
Author Information
- Joaquim Mullol1⇑,
- Giorgio Walter Canonica2,
- Martin Wagenmann3,
- Andre Coste4,
- Peter Hellings5,
- Scott Nash6,
- Siddhesh Kamat6,
- Urvi Mujumdar7,
- Jérôme Msihid8,
- Asif H Khan8,
- Shahid Siddiqui6,
- Juby A Jacob-Nara7,
- Yamo Deniz6 and
- Paul Rowe9
- 1Hospital Clínic, IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Catalonia, Spain
- 2Asthma & Allergy Clinic, Department of Biomedical Sciences, Humanitas University & IRCCS Humanitas Research Hospital, Milan, Italy
- 3Department of Otorhinolaryngology, Düsseldorf University Hospital (UKD), Düsseldorf, Germany
- 4Henri Mondor University Hospital of Creteil, Creteil, France
- 5Department of Otorhinolaryngology—Head and Neck Surgery, University Hospitals Leuven, Leuven, Belgium
- 6Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States of America
- 7Sanofi, Cambridge, MA, United States of America
- 8Sanofi, Chilly-Mazarin, France
- 9Sanofi, Bridgewater, NJ, United States of America
- Joaquim Mullol, Hospital Clínic, IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Catalonia, Spain. E-mail: jmullolmiret{at}gmail.com
Article usage
Altmetrics
Vol 58 Issue suppl 65
Table of Contents
SNOT-22 items and association with objective measures in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from SINUS-24 and SINUS-52 trials
